By continuing to browse the site you are agreeing to our use of cookies and similar tracking technologies described in our privacy policy.

Search

Resource Library

Home
Test, Evaluate, Monitor
Treatment-Naive
Treatment-Experienced Patients
Unique & Key Populations
About

Resource Library

Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1

Journal

N Engl J Med

Year of Publication

2015

Volume

373

Issue

8

Pagination

705-713

Authors

S. Naggie
C. Cooper
M. Saag
K. Workowski
P Ruane
W.J. Towner
K. Marks
A. Luetkemeyer
R.P. Baden
P.E. Sax
E Gane
J. Santana-Bagur
L.M. Stamm
J.C. Yang
P. German
H. Dvory-Sobol
L. Ni
P.S. Pang
J McHutchison
C.A. Stedman
J.O. Morales-Ramirez
N. Brau
D. Jayaweera
A.E. Colson
P. Tebas
D.K. Wong
D. Dieterich
M Sulkowski
ION-4 Investigators

Keywords

Alabama Antiretroviral Baltimore Boston California Canada Cities Diarrhea efavirenz emtricitabine England Fatigue Genotype genotype 1 HCV Headache Health hepatitis Hepatitis C hepatitis C virus Hiv-1 Human Israel Liver Los Angeles Medicine methods New England New York New Zealand NS5A inhibitor Patients Philadelphia Puerto Rico raltegravir Research rilpivirine San Francisco sofosbuvir sustained virologic response tenofovir therapy treatment Universities Veterans

Type of Article

Journal Article

Test, Evaluate, Monitor
Treatment-Naive
Treatment-Experienced Patients
Unique & Key Populations

Resource Library
About Us
Announcements
Contact Us

Terms of Use
Privacy Policy
Cookies Policy
Accessibility

© 2025 HCV Guidelines All right reserved.

Website by Yoko Co